Literature DB >> 18598276

Transfusion practice in military trauma.

J R Hess1, J B Holcomb.   

Abstract

Modern warfare causes severe injuries, and despite rapid transportation to theater regional trauma centers, casualties frequently arrive coagulopathic and in shock. Conventional resuscitation beginning with crystalloid fluids to treat shock causes further dilutional coagulopathy and increased hemorrhagic loss of platelets and coagulation factors. Established coagulopathy was difficult to reverse in the face of uncontrolled hemorrhage. Because many of the casualties met conventional plasma and platelet transfusion criteria on admission, thawed AB plasma was prepositioned in the trauma receiving area and used in a 1:1 ratio with red cells for resuscitation and fresh whole blood was used as a source of platelets. Retrospective assessments of this 1:1 therapy strongly suggested that it resulted in improved hemostasis, shorter ventilator times, and improved survival. Component therapy, when available, appears to be as effective as fresh whole blood. In field emergencies, fresh whole blood can be lifesaving.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598276     DOI: 10.1111/j.1365-3148.2008.00855.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  10 in total

Review 1.  The pathophysiology, diagnosis and treatment of the acute coagulopathy of trauma and shock: a literature review.

Authors:  J Kaczynski; M Wilczynska; L Fligelstone; J Hilton
Journal:  Eur J Trauma Emerg Surg       Date:  2013-12-12       Impact factor: 3.693

2.  Trends in transfusion of trauma victims--evaluation of changes in clinical practice.

Authors:  Anders R Nakstad; Nils O Skaga; Johan Pillgram-Larsen; Berit Gran; Hans E Heier
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-04-11       Impact factor: 2.953

Review 3.  TACTIC: Trans-Agency Consortium for Trauma-Induced Coagulopathy.

Authors:  K G Mann; K Freeman
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

Review 4.  Biomimetic Strategies To Treat Traumatic Brain Injury by Leveraging Fibrinogen.

Authors:  Ashley C Brown; Erin Lavik; Sarah E Stabenfeldt
Journal:  Bioconjug Chem       Date:  2019-07-05       Impact factor: 4.774

5.  Mortality in female war veterans of operations enduring freedom and Iraqi freedom.

Authors:  Jessica D Cross; Anthony E Johnson; Joseph C Wenke; Michael J Bosse; James R Ficke
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

6.  The use of whole blood in traumatic bleeding: a systematic review.

Authors:  Mario Cruciani; Massimo Franchini; Carlo Mengoli; Giuseppe Marano; Ilaria Pati; Francesca Masiello; Eva Veropalumbo; Simonetta Pupella; Stefania Vaglio; Vanessa Agostini; Giancarlo Maria Liumbruno
Journal:  Intern Emerg Med       Date:  2020-09-15       Impact factor: 3.397

7.  Murine blood banking: characterization and comparisons to human blood.

Authors:  Amy T Makley; Michael D Goodman; Lou Ann W Friend; Jay A Johannigman; Warren C Dorlac; Alex B Lentsch; Timothy A Pritts
Journal:  Shock       Date:  2010-07       Impact factor: 3.454

Review 8.  Evolution of the role of army transfusion services in the management of trauma patients and battle casualties with massive hemorrhage.

Authors:  R S Sarkar; J Philip; S Kumar; Pramod Yadav
Journal:  Med J Armed Forces India       Date:  2012-08-21

9.  Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma.

Authors:  Andrew J Shoffstall; Lydia M Everhart; Matthew E Varley; Eric S Soehnlen; Adam M Shick; Jeffrey S Ustin; Erin B Lavik
Journal:  Biomacromolecules       Date:  2013-07-24       Impact factor: 6.988

10.  Transfusion: -80°C Frozen Blood Products Are Safe and Effective in Military Casualty Care.

Authors:  Femke Noorman; Thijs T C F van Dongen; Marie-Christine J Plat; John F Badloe; John R Hess; Rigo Hoencamp
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.